Q3 revenues grew 21% y/y to $15M, and AEBITDA improved 13% to $6M driven by customer D and new wins. However, 2024 revenue guidance was revised down by 23% to $54M due to delays in deal closures. 
EROS C3 hiccups. Recent anomalies reduced EROS C3’s lifespan from 12 to 8 yrs, increasing annual D&A by $7.5M. While functionality has been resorted, we are lowering 2024 revenue and AEBITDA by $11M and $7M, respectively, to reflect overall operational challenges.
Strengthens Backlog. ISI added ~$84.5M in new business and expansions during Q3, reaching a contract book of $196M. Significant demand was observed across AI-Analytics and infra solutions.